Mechanism of Action: 5-alpha Reductase Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: 5-alpha Reductase Inhibitors
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon | PROSCAR | finasteride | TABLET;ORAL | 020180-001 | Jun 19, 1992 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Organon | PROPECIA | finasteride | TABLET;ORAL | 020788-001 | Dec 19, 1997 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Waylis Therap | JALYN | dutasteride; tamsulosin hydrochloride | CAPSULE;ORAL | 022460-001 | Jun 14, 2010 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Aurobindo Pharma | FINASTERIDE | finasteride | TABLET;ORAL | 078341-001 | Oct 30, 2007 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Hetero Labs Ltd Iii | FINASTERIDE | finasteride | TABLET;ORAL | 090060-001 | Jul 1, 2013 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Cipla | FINASTERIDE | finasteride | TABLET;ORAL | 077335-001 | Nov 20, 2014 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Aurobindo Pharma Ltd | FINASTERIDE | finasteride | TABLET;ORAL | 203687-001 | Nov 5, 2013 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
